Medicine for preventing and treating cerebrovascular dementia
A technology for cerebrovascular dementia and drugs, which is applied in drug combinations, medical raw materials derived from leeches/helminths, and pharmaceutical formulations, etc., can solve the problems of difficulty in popularization, high cost, and unbearable for patients.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment Construction
[0021] Preparation of raw materials used in the present invention: Ginseng 8g, Panax notoginseng 5g, Schisandra 6g, Cornus officinalis 10g, Rehmannia glutinosa 20g, Shouwu 15g, Cordyceps 8g, fried Eucommia 11g, antler 2g, leech 1.5g, Shichangpu 6g, Polygala 3g, Danshen 10g, turtle shell 20g. The above-mentioned medicines are made into dense pills through the traditional process of traditional Chinese medicine, and each pill weighs 3.5g.
[0022] The present invention is through clinical observation and experiment, and result is as follows:
[0023] 1. Selected clinical cases: in line with the diagnostic criteria of the International Classification of Diseases (ICD-10) as mild to moderate dementia, referring to the Hasegawa Dementia Scale (HDC), and presented at the National Symposium on Alzheimer's Disease in Beijing in May 1990 Based on the revised "Diagnosis and Curative Effect Evaluation Criteria of Alzheimer's Disease" (see "Journal of Traditional Chinese Medicine" Volume...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com